expert reaction to observational study of GLP-1 receptor agonists and metformin in people with type 2 diabetes and risk of dementia – Science Media Centre

  1. expert reaction to observational study of GLP-1 receptor agonists and metformin in people with type 2 diabetes and risk of dementia  Science Media Centre
  2. Weight loss drugs may lower risk of dementia, stroke: Study  NewsNation
  3. GLP-1 Studies Show Potential to Reduce Brian Injury Complications and Prevent Strokes  PharmExec
  4. Diabetes drugs like Ozempic may help mitigate effects of stroke and brain haemorrhages  NeuroNews International
  5. Semaglutide (Ozempic, Wegovy) Linked to Lower Dementia Risk, According to Study  Muscle & Fitness

Continue Reading